Who Supplies Propranolol? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Propranolol exports, with 196+ registered manufacturers shipping to buyers across 99+ countries — yet a handful of companies dominate the shipments. IPCA LABORATORIES LIMITED holds the largest share at 43.6% (export value: $25.3M). Close behind, PAR FORMULATIONS PRIVATE LIMITED (27.5%, $16.0M). INTAS PHARMACEUTICALS LIMITED (4.1%, $2.4M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Propranolol? Top Manufacturers & Their Buyers
Flow of Propranolol from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Propranolol Supplier Network — Key Market Intelligence
The Propranolol export market from India is led by IPCA LABORATORIES LIMITED, which alone commands a 43.6% share, shipping $25.3M worth of product across 55 shipments. The second-largest exporter, PAR FORMULATIONS PRIVATE LIMITED, contributes $16.0M (27.5%) to the overall market. Combined, the top two suppliers alone account for 71.2% of all Propranolol exports, indicating a relatively concentrated supply base.
Across all 196 tracked manufacturers, the total Propranolol export value stands at $58.1M from 4.0K shipments. The market average shipment value is $14.6K. The single largest buyer relationship in terms of trade value is UPS SUPPLY CHAIN SOL, receiving $14.6M worth of product.
The combined buyer network spans 13 named purchasing companies, including APOTEX PTY LTD, APOTEX PTY LIMITED, UPS SUPPLY CHAIN SOL, LUPIN PHARMA CANADA , MILPHARM LIMITED, and 8 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1IPCA LABORATORIES LIMITED
IPCA LABORATORIES LIMITED is the first-largest Propranolol exporter from India, with a market share of 43.6% and a total export value of $25.3M across 55 shipments. Their average shipment value of $460.4K is above the market average of $14.6K, suggesting premium or bulk contract pricing.
IPCA LABORATORIES LIMITED serves 4 named buyers in our database. NA is the dominant customer, accounting for 98.4% of this supplier's tracked business. Top customers include:
• NA — $24.9M across 54 shipments (98.4% of this supplier's total exports)
• APOTEX PTY LTD — $198.8K across 0 shipments (0.8% of this supplier's total exports)
• TO THE ORDER — $165.2K across 0 shipments (0.7% of this supplier's total exports)
• APOTEX PTY LIMITED — $35.8K across 0 shipments (0.1% of this supplier's total exports)
Key Insight: IPCA LABORATORIES LIMITED's per-shipment value of $460.4K is 3063% above the market average of $14.6K, consistent with large-order contracts or value-added formulations.
2PAR FORMULATIONS PRIVATE LIMITED
PAR FORMULATIONS PRIVATE LIMITED is the second-largest Propranolol exporter from India, with a market share of 27.5% and a total export value of $16.0M across 109 shipments. Their average shipment value of $146.7K is above the market average of $14.6K, suggesting premium or bulk contract pricing.
PAR FORMULATIONS PRIVATE LIMITED serves 3 named buyers in our database. UPS SUPPLY CHAIN SOL is the dominant customer, accounting for 91.4% of this supplier's tracked business. Top customers include:
• UPS SUPPLY CHAIN SOL — $14.6M across 100 shipments (91.4% of this supplier's total exports)
• UPS SUPPLY CHAIN SOL — $1.0M across 7 shipments (6.3% of this supplier's total exports)
• UPS SUPPLY CHAIN SOL — $363.8K across 2 shipments (2.3% of this supplier's total exports)
Key Insight: PAR FORMULATIONS PRIVATE LIMITED's per-shipment value of $146.7K is 908% above the market average of $14.6K, consistent with large-order contracts or value-added formulations.
3INTAS PHARMACEUTICALS LIMITED
INTAS PHARMACEUTICALS LIMITED is the third-largest Propranolol exporter from India, with a market share of 4.1% and a total export value of $2.4M across 420 shipments. Their average shipment value of $5.7K is below the market average of $14.6K, reflecting a high-volume, competitive pricing strategy.
INTAS PHARMACEUTICALS LIMITED serves 1 named buyer in our database. LUPIN PHARMA CANADA is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• LUPIN PHARMA CANADA — $2.4M across 420 shipments (100.0% of this supplier's total exports)
Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (420 shipments) at a per-shipment value of $5.7K, indicating a broad distribution network with many smaller, regular orders.
4AUROBINDO PHARMA LTD
AUROBINDO PHARMA LTD is the fourth-largest Propranolol exporter from India, with a market share of 3.6% and a total export value of $2.1M across 103 shipments. Their average shipment value of $20.5K is above the market average of $14.6K, suggesting premium or bulk contract pricing.
AUROBINDO PHARMA LTD serves 5 named buyers in our database. MILPHARM LIMITED, is the dominant customer, accounting for 75.5% of this supplier's tracked business. Top customers include:
• MILPHARM LIMITED, — $1.6M across 78 shipments (75.5% of this supplier's total exports)
• APL SWIFT SERVICES (MALTA) LIMITED — $287.5K across 14 shipments (13.6% of this supplier's total exports)
• ARROW GENERIQUES, — $125.2K across 6 shipments (5.9% of this supplier's total exports)
• ARROW GENERIQUES, 26 — $60.8K across 3 shipments (2.9% of this supplier's total exports)
• ARROW GENERIQUES, — $42.7K across 2 shipments (2.0% of this supplier's total exports)
Key Insight: AUROBINDO PHARMA LTD's per-shipment value of $20.5K is 40% above the market average of $14.6K, consistent with large-order contracts or value-added formulations.
5AMNEAL PHARMACEUTICALS PRIVATE LIMITED
AMNEAL PHARMACEUTICALS PRIVATE LIMITED is the fifth-largest Propranolol exporter from India, with a market share of 2.0% and a total export value of $1.1M across 8 shipments. Their average shipment value of $142.0K is above the market average of $14.6K, suggesting premium or bulk contract pricing.
AMNEAL PHARMACEUTICALS PRIVATE LIMITED serves 1 named buyer in our database. XXNEAXXPHAXXACEXXICAXX LXX (NXX is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• XXNEAXXPHAXXACEXXICAXX LXX (NXX — $1.1M across 8 shipments (100.0% of this supplier's total exports)
Key Insight: AMNEAL PHARMACEUTICALS PRIVATE LIMITED's per-shipment value of $142.0K is 875% above the market average of $14.6K, consistent with large-order contracts or value-added formulations.
6AMNEAL PHARMACEUTICALS COMPANY (I) PRIVATE LIMITED
AMNEAL PHARMACEUTICALS COMPANY (I) PRIVATE LIMITED is the fifth-largest Propranolol exporter from India, with a market share of 1.6% and a total export value of $905.1K across 11 shipments. Their average shipment value of $82.3K is above the market average of $14.6K, suggesting premium or bulk contract pricing.
AMNEAL PHARMACEUTICALS COMPANY (I) PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• ACCORD HEALTHCARE, SLU — $229.4K across 3 shipments (25.4% of this supplier's total exports)
• BROCACEF NL : HUB — $226.6K across 3 shipments (25.0% of this supplier's total exports)
• ACCORD HEALTHCARE, SLU — $187.1K across 2 shipments (20.7% of this supplier's total exports)
• BROCACEF NL HUB BROCACEF HEALTHCAR — $149.3K across 2 shipments (16.5% of this supplier's total exports)
• ACCORD HEALTHCARE PO — $112.7K across 1 shipments (12.4% of this supplier's total exports)
Key Insight: AMNEAL PHARMACEUTICALS COMPANY (I) PRIVATE LIMITED's per-shipment value of $82.3K is 465% above the market average of $14.6K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Propranolol Flows
Once Propranolol leaves the manufacturing plants of companies like IPCA LABORATORIES LIMITED and PAR FORMULATIONS PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $58.1M. Australia absorbs the largest share at 43.9% ($25.5M), followed by United States (37.5%) and United Kingdom (5.5%).
In Australia — the top destination — named importers include APOTEX PTY LTD. In United States, key buyers are XXNEAXXPHAXXACEXXICAXX LXX (NXX, AMNEAL PHARMACEUTICALS LLC NJ, ACTAVIS LABORATORIES FL, INC..
This geographic spread reflects Propranolol's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Propranolol Go? Top Importing Countries & Their Buyers
Trade flow of Propranolol exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Australia
Australia ranks as the first-largest destination for Propranolol imports from India, with a total trade value of $25.5M across 14 shipments — representing a 43.9% share of all Propranolol exports. The average shipment value of $1.8M is above the global average of $14.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Propranolol importers in Australia: APOTEX PTY LTD is the largest buyer, accounting for 2.9% ($734.5K) of this market's total imports.
• APOTEX PTY LTD — $734.5K (2.9% of Australia's total)
Key Insight: Australia's per-shipment average of $1.8M (12414% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Australia is a key market for Propranolol imports from India.
2United States
United States ranks as the second-largest destination for Propranolol imports from India, with a total trade value of $21.7M across 55 shipments — representing a 37.5% share of all Propranolol exports. The average shipment value of $395.4K is above the global average of $14.6K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Propranolol importers in United States: XXNEAXXPHAXXACEXXICAXX LXX (NXX is the largest buyer, accounting for 5.2% ($1.1M) of this market's total imports.
• XXNEAXXPHAXXACEXXICAXX LXX (NXX — $1.1M (5.2% of United States's total)
• AMNEAL PHARMACEUTICALS LLC NJ — $1.1M (5.0% of United States's total)
• ACTAVIS LABORATORIES FL, INC. — $660.5K (3.0% of United States's total)
Key Insight: United States's per-shipment average of $395.4K (2617% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Propranolol imports from India.
3United Kingdom
United Kingdom ranks as the third-largest destination for Propranolol imports from India, with a total trade value of $3.2M across 55 shipments — representing a 5.5% share of all Propranolol exports. The average shipment value of $57.5K is above the global average of $14.6K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Propranolol importers in United Kingdom: MILPHARM LIMITED, is the largest buyer, accounting for 55.8% ($1.8M) of this market's total imports.
• MILPHARM LIMITED, — $1.8M (55.8% of United Kingdom's total)
• RELONCHEM LTD CHESHIRE HOUSE, — $559.5K (17.7% of United Kingdom's total)
• NOUMED LIFE SCIENCES LIMITED — $435.6K (13.8% of United Kingdom's total)
Key Insight: United Kingdom's per-shipment average of $57.5K (295% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Kingdom is a key market for Propranolol imports from India.
4Canada
Canada ranks as the fourth-largest destination for Propranolol imports from India, with a total trade value of $2.4M across 0 shipments — representing a 4.1% share of all Propranolol exports. The average shipment value of $2.4M is above the global average of $14.6K, indicating high-value procurement contracts or branded formulations.
Key Insight: Canada's per-shipment average of $2.4M (16419% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Propranolol imports from India.
5Netherlands
Netherlands ranks as the fifth-largest destination for Propranolol imports from India, with a total trade value of $1.1M across 68 shipments — representing a 1.8% share of all Propranolol exports. The average shipment value of $15.7K is above the global average of $14.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Propranolol importers in Netherlands: BROCACEF NL : HUB is the largest buyer, accounting for 41.3% ($441.6K) of this market's total imports.
• BROCACEF NL : HUB — $441.6K (41.3% of Netherlands's total)
• BROCACEF NL HUB BROCACEF HEALTHCAR — $202.2K (18.9% of Netherlands's total)
Key Insight: Netherlands's per-shipment average of $15.7K (8% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Netherlands is a key market for Propranolol imports from India.
People Also Ask — Propranolol Supplier & Trade Network
Who are the top suppliers of Propranolol from India?+
Which companies buy Propranolol from Indian manufacturers?+
Where does Propranolol exported from India go?+
What is the market share of the top Propranolol supplier from India?+
What is the average shipment value for Propranolol exports from India?+
Is Propranolol manufactured in India and exported globally?+
Which country imports the most Propranolol from India?+
Who are the buyers of Propranolol in United States?+
How concentrated is the Propranolol supplier market in India?+
How do I find verified buyers for Propranolol in specific countries?+
Propranolol Trade Network — Key Takeaways
- 1IPCA LABORATORIES LIMITED is India's dominant Propranolol exporter with a 43.6% market share and $25.3M in total exports — making it the single most important sourcing entity in this market.
- 2The top 196 suppliers collectively account for 82.4% of all tracked Propranolol exports, with a combined trade value of $58.1M.
- 3Australia is the largest destination market, absorbing 43.9% of India's Propranolol exports ($25.5M). United States (37.5%) and United Kingdom (5.5%) follow.
- 4With 4.0K total shipments averaging $14.6K each, the Propranolol export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include APOTEX PTY LTD, APOTEX PTY LIMITED, UPS SUPPLY CHAIN SOL, UPS SUPPLY CHAIN SOL — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 4 customers
6 suppliers → 99 countries
Network value: $58.1M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Propranolol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Propranolol.
- 2.Flow Mapping: 196 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,988 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 99 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,988 Verified Shipments
196 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists